Appropriate controls are not exercised over.
Inspection Record
ROSLIN CELL THERAPIES LIMITED — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not followed.
The responsibilities and procedures applicable to the quality control unit are not fully followed.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Sanofi Pasteur2023-09-29 · US FDASimilar to finding 2 Procedures designed to prevent microbiological contamination ofdrug products purporting to be sterile are not followed.
- Eugia Steriles Private Limited2026-06-19 · US FDASimilar to finding 2 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established, written and followed.
- GSK Vaccines GmbH2024-03-06 · US FDASimilar to finding 2 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and followed.
- Alembic Pharmaceuticals Limited2016-03-25 · US FDASimilar to finding 3 The responsibilities and procedures applicable to the quality control unit are not fully followed.
- Sun Pharmaceutical Industries Ltd.2016-12-01 · US FDASimilar to finding 3 The responsibilities and procedures applicable to the quality control unit are not fully followed.
A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.